Gas Phase Reaction of Substituted Isoquinolines to Carboxylic Acids in Ion Trap and Triple Quadrupole Mass Spectrometers after Electrospray Ionization and Collision-Induced Dissociation

Journal of the American Society for Mass Spectrometry

Volumn 19, Issue 1, 2008, Pages 151-158

  Thevis, Mario ^a   Kohler, Maxie ^a   Schlörer, Nils ^b   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; DISSOCIATION; ELECTROSPRAY IONIZATION; MASS SPECTROMETERS; METABOLISM; PHASE TRANSITIONS; CARBOXYLIC ACIDS; CHEMICAL ACTIVATION; CHEMICAL ANALYSIS; ESTERIFICATION; ESTERS; EXPERIMENTS; GASES; IONIZATION OF GASES; IONS; MASS SPECTROMETRY; PH; PHASE INTERFACES; PROTONATION; SYNTHESIS (CHEMICAL);

COLLISION-INDUCED DISSOCIATION; GAS PHASE REACTION; SUBSTITUTED ISOQUINOLINES;

CARBOXYLIC ACIDS; ION EXCHANGE;

CARBENE; CARBOXYLIC ACID DERIVATIVE; ISOQUINOLINE DERIVATIVE;

ACCURACY; ADDITION REACTION; ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; COLLISIONALLY ACTIVATED DISSOCIATION; DISSOCIATION CONSTANT; DOPING; ELECTROSPRAY MASS SPECTROMETRY; FORENSIC IDENTIFICATION; ION TRAP MASS SPECTROMETRY; PROTON TRANSPORT; QUADRUPOLE MASS SPECTROMETRY; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; TANDEM MASS SPECTROMETRY;

CARBOXYLIC ACIDS; CHROMATOGRAPHY, LIQUID; GASES; ISOQUINOLINES; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

COLLISION-INDUCED DISSOCIATION; COLLISIONAL ACTIVATION; DISSOCIATION PATHWAYS; DOPING CONTROL ANALYSIS; GAS-PHASE INTERMEDIATES; PROTONATED MOLECULES; TANDEM MASS SPECTROMETRY; TRIPLE-QUADRUPOLE MASS SPECTROMETER;

EID: 38349077239     PISSN: 10440305     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jasms.2007.11.003     Document Type: Article

References (33)

1. Pihlajaniemi T., Myllyla R., and Kivirikko K.I. Prolyl 4-Hydroxylase and Its Role in Collagen Synthesis. J. Hepatol 13 Supp 3 (1991) S2-S7
2. Kivirikko K.I., Helaakoski T., Tasanen K., Vuori K., Myllyla R., Parkkonen T., and Pihlajaniemi T. Molecular Biology of Prolyl 4-Hydroxylase. Ann. N.Y. Acad. Sci 580 (1990) 132-142
3. Prockop D.J., and Kivirikko K.I. Collagens: Molecular Biology, Diseases, and Potentials for Therapy. Annu. Rev. Biochem 64 (1995) 403-434
4. Hirsilä M., Koivunen P., Günzler V., Kivirikko K., and Myllyharju J. Characterization of the Human Prolyl 4-Hydroxylases that Modify the Hypoxia-Inducible Factor. J. Biol. Chem 278 (2003) 30772-30780
5. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl hydroxylation. Cell 107 (2001) 43-54
6. Bruick R.K., and McKnight S.L. A Conserved Family of Prolyl-4-Hydroxylases that Modify HIF. Science 294 (2001) 1337-1340
7. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Targeting of HIF-α to the von Hippel-Lindau ubiquitilation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
8. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin Jr. W.G. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing. Science 292 (2001) 464-468
9. Yu F., White S.B., Zhao Q., and Lee F.S. HIF-1α Binding to VHL is Regulated by Stimulus-Sensitive Proline Hydroxylation. Proc. Natl. Acad. Sci. U.S.A 98 (2001) 9630-9635
10. Safran M., and Kaelin Jr. W.G. HIF Hydroxylation and the Mammalian Oxygen-Sensing Pathway. J. Clin. Invest 111 (2003) 779-783
11. Metzen E., and Ratcliffe P. HIF Hydroxylation and Cellular Oxygen Sensing. Biol. Chem 385 (2004) 223-230
12. Bruick R. Oxygen Sensing in the Hypoxic Response Pathway: Regulation of the Hypoxia-Inducible Transcription Factor. Genes Dev 17 (2003) 2614-2623
13. Warnecke C., Griethe W., Weidemann A., Jurgensen J., Willam C., Bachmann S., Ivashchenko Y., Wagner I., Frei U., Wiesener M., and Eckardt K. Activation of the Hypoxia-Inducible Factor Pathway and Stimulation of Angiogenesis by Application of Prolyl Hydroxylase Inhibitors. FASEB J 17 (2003) 1186-1188
14. Bruick R.K., and McKnight S.L. Building Better Vasculature. Genes Dev 15 (2001) 2497-2502
15. Jelkmann W. Molecular Biology of Erythropoietin. Intern. Med 43 (2004) 649-659
16. Ratcliffe P. From Erythropoietin to Oxygen: Hypoxia-Inducible Factor Hydroxylases and the Hypoxia Signal Pathway. Blood Purif 20 (2002) 445-450
17. del Peso L., Castellanos M., Temes E., Martin-Puig S., Cuevas Y., Olmos G., and Landazuri M. The von Hippel Lindau/Hypoxia-Inducible Factor (HIF) Pathway Regulates the Transcription of the HIF-Proline Hydroxylase Genes in Response to Low Oxygen. J. Biol. Chem 278 (2003) 48690-48695
18. Nietfeld J., de Jong L., and Kemp A. The Influence of 2-Oxoglutarate on the Activity of Prolyl 4-Hydroxylase. Biochim. Biophys. Acta 704 (1982) 321-325
19. Mole D., Schlemminger I., McNeill L., Hewitson K., Pugh C., Ratcliffe P., and Schofield C. 2-Oxoglutarate Analogue Inhibitors of HIF Prolyl Hydroxylase. Bioorg. Med. Chem. Lett 13 (2003) 2677-2680
20. Cunliffe C., and Franklin T. Inhibition of Prolyl 4-Hydroxylase by Hydroxyanthraquinones. Biochem. J 239 (1986) 311-315
21. Dowell R., and Hadley E. Novel Inhibitors of Prolyl 4-Hydroxylase. J. Med. Chem 35 (1992) 800-804
22. Wang J., Buss J., Chen G., Ponka P., and Pantopoulos K. The Prolyl 4-Hydroxylase Inhibitor Ethyl-3,4-Dihydroxybenzoate Generates Effective Iron Deficiency in Cultured Cells. FEBS Lett 529 (2002) 309-312
23. Warshakoon N.C., Wu S., Boyer A., Kawamoto R., Sheville J., Renock S., Xu K., Pokross M., Zhou S., Winter C., Walter R., Mekel M., and Evdokimov A.G. Structure-Based Design, Synthesis, and SAR Evaluation of a New Series of 8-Hydroxyquinolines as HIF-1α Prolyl Hydroxylase Inhibitors. Bioorg. Med. Chem. Lett 16 (2006) 5517-5522
24. Warshakoon N.C., Wu S., Boyer A., Kawamoto R., Renock S., Xu K., Pokross M., Evdokimov A.G., Zhou S., Winter C., Walter R., and Mekel M. Design and Synthesis of a Series of Novel Pyrazolopyridines as HIF-1α Prolyl Hydroxylase Inhibitors. Bioorg. Med. Chem. Lett 16 (2006) 5687-5690
25. Tucker H., and Thomas D. Novel Inhibitors of Prolyl 4-Hydroxylase. 2. 5-Amide Substituted pyridine-2-carboxylic acids. J. Med. Chem 35 (1992) 804-807
26. Hales N., and Beattie J. Novel Inhibitors of Prolyl 4-Hydroxylase. 5. The Intriguing Structure-Activity Relationships Seen with 2,2′-Bipyridine and Its 5,5′-Dicarboxylic Acid Derivatives. J. Med. Chem 36 (1993) 3853-3858
27. Cunliffe C., Franklin T., Hales N., and Hill G. Novel Inhibitors of Prolyl 4-Hydroxylase. 3. Inhibition by the Substrate Analogue N-Oxaloglycine and Its Derivatives. J. Med. Chem 35 (1992) 2652-2658
28. Baader E., Tschank G., Baringhaus K., Burghard H., and Gunzler V. Inhibition of Prolyl 4-Hydroxylase by Oxalyl Amino Acid Derivatives in Vitro, in Isolated Microsomes and in Embryonic Chicken Tissues. Biochem. J 300 (1994) 525-530
29. Fibrogen Inc. Development Pipeline. 2007, http://www.fibrogen.com/pipeline/chart/anemia.html#mid (accessed 09-20-2007).
30. Wang Q., Gou G., Guenzler V., Neff T., Klaus S., Turtle E., Molineaux C., Yeowell D., and Lin A. Stimulation of Erythropoiesis and Treatment of Anemia in Rodents by Oral Administration of FG-2216, a Novel HIF-Prolyl Hydroxylase Inhibitor. J. Am. Soc. Nephrol 15 (2004) 773A
31. Hsieh M.M., Linde N.S., Wynter A., Metzger M., Wong C., Langsetmo I., Lin A., Smith R., Rodgers G.P., Donahue R.E., Klaus S.J., and Tisdale J.F. HIF Prolyl Hydroxylase Inhibition Results in Endogenous Erythropoietin Induction, Erythrocytosis, and Modest Fetal Hemoglobin Expression in Rhesus Macaques. Blood 110 (2007) 2140-2147
32. Suzuki M., Nunami K., Matsumoto K., Yoneda N., and Miyoshi M. A Facile Synthesis of 1-Oxo-1,2-Dihydroxyisoquinoline-3-Carboxylate and 2-Pyridone-6-Carboxylate Derivatives. Synthesis (1978) 461-462
33. Fibrogen. EP 1 538 160 A1, European Patent Office: 2005.